Ainos, MacKay Memorial Hospital, and Topco Scientific Partner to Advance Smell AI Deployment in High-Risk Hospital Environments

Collaboration aims to expand Ainos' AI Nose platform from industrial safety into healthcare infrastructure

Apr. 8, 2026 at 6:35pm

Got story updates? Submit your updates here. ›

A highly detailed, glowing 3D illustration of a hospital's gas and HVAC infrastructure, with a complex network of pipes, valves, and sensors illuminated by neon cyan and magenta lights, conceptually representing the advanced sensing capabilities of Ainos' AI Nose technology.Ainos' AI Nose platform aims to establish a new layer of environmental intelligence across high-risk hospital systems, enabling earlier detection of emerging risks.Houston Today

Ainos, Inc. announced a partnership with MacKay Memorial Hospital and Topco Scientific Co., Ltd. to deploy its AI Nose technology across high-risk hospital environments. The initial deployment, beginning in April 2026, will focus on environmental monitoring and safety across four critical hospital areas: power and electromechanical systems, gas and HVAC infrastructure, chemical handling and storage environments, and clinical testing and laboratory settings, including MRI facilities.

Why it matters

Hospitals are complex, high-risk environments with stringent monitoring requirements. This collaboration marks a key step in Ainos' commercialization roadmap, expanding its Smell AI platform from industrial and environmental safety into healthcare infrastructure and enabling earlier awareness of emerging risks to support a shift from reactive management to preventive operations.

The details

The partnership is designed to build a unified sensing capability across environments, enabling AI Nose to monitor and interpret multiple risk domains within a single hospital system. By capturing and modeling multi-dimensional scent signals, the system aims to establish baseline profiles for different environments and detect deviations in real time, enabling monitoring of environmental changes associated with infection risk, managing hazardous chemicals and specialty gases, and detecting anomalies in electrical and infrastructure systems at early stages.

  • The initial deployment will begin in April 2026.

The players

Ainos, Inc.

A dual-platform AI and biotech company pioneering smelltech and immune therapeutics. Its AI Nose platform and smell language model (SLM) digitize scent into Smell ID, a machine-readable data format, powering intelligent sensing across robotics, smart factories, and healthcare.

MacKay Memorial Hospital

A hospital partner in the collaboration to deploy Ainos' AI Nose technology across high-risk hospital environments.

Topco Scientific Co., Ltd.

A partner in the collaboration, providing system integration capabilities to enable the deployment of Ainos' AI Nose platform.

Got photos? Submit your photos here. ›

What they’re saying

“Through this collaboration, AI Nose is entering one of the most demanding real-world environments. We are building a new layer of environmental perception, enabling earlier awareness across infection, chemical, and infrastructure risks.”

— Eddy Tsai, Chairman, President and Chief Executive Officer of Ainos

What’s next

The partnership establishes a replicable model for scaling Ainos' AI Nose platform across healthcare systems.

The takeaway

This collaboration marks a transition from deploying standalone sensing devices to enabling platform-level adoption of Ainos' Smell AI technology in high-risk hospital environments, laying the foundation for scalable healthcare expansion.